News: Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,682.00GBp
18 Dec 2014
Price Change (% chg)

160.00p (+3.54%)
Prev Close
4,522.00p
Open
4,618.00p
Day's High
4,707.00p
Day's Low
4,573.00p
Volume
2,365,816
Avg. Vol
3,225,821
52-wk High
5,470.00p
52-wk Low
2,774.00p

Search Stocks
Select another date:

EXclusive: Paulson & Co takes stake in Salix on heels of inventory issues - sources

- Hedge fund Paulson & Co has taken a stake in specialty pharmaceuticals company Salix Pharmaceuticals Ltd as the company recovers from inventory issues and the departure of its chief financial officer, according to people familiar with the matter.

Shire considering bid for NPS Pharmaceuticals: Bloomberg

- Dublin-based Shire Plc, whose proposed sale to AbbVie Inc fell apart in October, is considering an offer for U.S-based drug developer NPS Pharmaceuticals Inc, Bloomberg reported, citing people familiar with the matter.

Deals of the day- Mergers and acquisitions

(Adds Shire, Carrefour, Clessidra, CMVM, Snam, Eni, Lala, Lucchini and KGHM)

Shire considering bid for NPS Pharmaceuticals: Bloomberg

- Dublin-based Shire Plc, whose proposed sale to AbbVie Inc fell apart in October, is considering an offer for U.S-based drug developer NPS Pharmaceuticals Inc, Bloomberg reported, citing people familiar with the matter.

Shire considering bid for NPS Pharmaceuticals - Bloomberg

Dec 17 - Dublin-based Shire Plc, whose proposed sale to AbbVie Inc fell apart in October, is considering an offer for U.S-based drug developer NPS Pharmaceuticals Inc, Bloomberg reported, citing people familiar with the matter.

BRIEF-Argen-X says partner Shire advances therapeutic antibody alliance

* arGen-X NV announces advancement of therapeutic antibody alliance with Shire

Shire CEO eyes deals, but no urgency to spend AbbVie breakup fee

NEW YORK - Shire PLC's chief executive said he sees no urgency to spend the windfall the Dublin-based drugmaker received when AbbVie walked away from a $55 billion takeover bid earlier this year.

Shire teams up with foundation to tackle cystic fibrosis

LONDON - Pharmaceutical company Shire said it would work with a specialist cystic fibrosis foundation on developing a technology to improve patients' lung function and reduce infections.

Shire teams up with foundation to tackle cystic fibrosis

LONDON, Dec 10 - Pharmaceutical company Shire said it would work with a specialist cystic fibrosis foundation on developing a technology to improve patients' lung function and reduce infections.

Drugs company Shire relocates 500 jobs to Massachusetts

LONDON, Nov 19 - Drugs company Shire said on Wednesday it would move over 500 jobs from its Chesterbrook, Pennsylvania site to Lexington, Massachusetts, to save costs by combining its worldwide R&D and commercial operations in two locations.

Select another date:
Search Stocks